The "MetaboMap" project |
Steven Moore |
NCI |
PLCO |
Apr 23, 2020 |
PLCO-615 |
The association of dietary and behavioral factors associated with total and cause-specific mortality |
Xin Xu |
The First Affiliated Hospital, School of Medicine, Zhejiang University |
PLCO |
Apr 23, 2020 |
PLCO-587 |
Prostate-specific antigen screening rates and factors associated with screening in American men |
Ming Liu |
Beijing Hospital |
PLCO |
Apr 16, 2020 |
PLCO-606 |
Estimating the probability of overdiagnosis in PLCO trial |
Jian-Lun Xu |
NCI |
PLCO |
Mar 25, 2020 |
PLCO-600 |
A systematic assessment of different environmental, lifestyle, medical and familial factors associated with risk of liver cancer and survival |
Youzhu Wei |
Fujian Medical University |
PLCO |
Mar 25, 2020 |
PLCO-604 |
Master Degree on Prostate Cancer Survival |
Katarzyna Adamska |
Warsaw School of Economics |
PLCO |
Mar 20, 2020 |
PLCO-596 |
Biomarkers of Exposure and Response to Coffee Intake |
Erikka Loftfield |
National Cancer Institute |
PLCO |
Mar 20, 2020 |
PLCO-599 |
Early Diagnosis of Asthma, Thyroid Cancer and Schizophrenia Diseases Using Computational Intelligence Techniques |
Sarah Alotaibi |
IAU |
PLCO |
Mar 20, 2020 |
PLCO-603 |
EEMS Methods Study Work |
Erikka Loftfield |
National Cancer Institute |
PLCO |
Mar 18, 2020 |
2020-9001 |
Aspirin use and risk of hepatocellular carcinoma incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Holli Loomans-Kropp |
National Cancer Institute |
PLCO |
Mar 18, 2020 |
PLCO-601 |
Dietary inflammatory potential and risk of liver cancer in the PLCO study |
Xuehong Zhang |
The Brigham and Women’s Hospital, Inc. |
PLCO |
Mar 16, 2020 |
PLCO-598 |
A Machine Learning Approach to Bladder Cancer Screening and Cancer Grade/Stage Differentiation |
Herbert Chase |
The Trustees of Columbia University in the City of New York |
PLCO |
Mar 16, 2020 |
PLCO-597 |
Association of colorectal polyps with dietary inflammation during screening colonoscopy in Men and Women |
Bhaumik Brahmbhatt |
Mayo Clinic |
PLCO |
Mar 16, 2020 |
PLCO-593 |
Risk Prediction Model for Endometrial Cancer using multiple Machine Learning Algorithms and Meta-Analysis |
Denis Mihaies |
Brunel Univeristy |
PLCO |
Mar 16, 2020 |
PLCO-590 |
Interpretable Artificial Intelligence to select patients that will benefit from lung cancer screening |
Jean-Emmanuel Bibault |
Stanford University |
PLCO |
Mar 5, 2020 |
PLCO-594 |
Personalizing colorectal treatment strategies through machine learning |
Jean-Emmanuel Bibault |
Stanford University |
PLCO |
Feb 27, 2020 |
PLCO-592 |
Treatment effect on the Survival Time of Lung Cancer Patients |
Jing Zhou |
Department of Family and Preventive Medicine |
PLCO |
Feb 27, 2020 |
PLCO-591 |
Developing a metabolite-based biomarker panel for prostate cancer detection and prognosis in African-American men |
Arun Sreekumar |
Baylor College of medicine |
PLCO |
Feb 19, 2020 |
PLCO-583 |
Second-hand smoke (SHS) and mortality in never-smoking women |
Neal Freedman |
NCI |
PLCO |
Feb 19, 2020 |
PLCO-586 |
A new mathematical model for the computation of optimal screening frequencies for lung and colorectal cancer |
Johannes Reiter |
Stanford University |
PLCO |
Feb 7, 2020 |
PLCO-581 |